Breaking News

Recipharm, PledPharma in Supply Pact

February 13, 2013

Manufactures material for Phase II PLIANT trial

Recipharm will supply clinical trial materials to PledPharma for its Phase IIb trial with PledOx, PLIANT, following the FDA’s IND approval. The material for PLIANT has been manufactured by Recipharm Pharmaceutical Development.
 
Recipharm Pharamaceutical Development’s general manager, Maria Lundberg, said, “We are delighted to contribute to the development of a new product that may reduce serious side-effects of the chemotherapy in patients treated for advanced colorectal cancer. Furthermore, manufacturing material for an FDA-approved clinical study reflects the highest standards of service quality and capabilities that Recipharm provides to its customers, meeting the expectations and demands of today’s competitive market place.”
 
Jacques Näsström, chief executive officer of PledPharma, said, "We are very pleased with the positive assessment by the FDA. Since the U.S. is perhaps the single most important market, it is particularly encouraging that we received approval for our study there.”

Related Contract Manufacturing:

  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks